Table 1.
Patient characteristics (n = 119).
| Variable | Number | (%) |
|---|---|---|
| Gender | ||
| Male | 43 | 36.1% |
| Female | 76 | 63.9% |
| Age | ||
| Mean (SD) | 58.7 | (14.2) |
| Localization | ||
| Skull base | 73 | 61.3% |
| Cerebral falx | 27 | 22.7% |
| Hemispheral convexity | 15 | 12.6% |
| Optic nerve sheath | 4 | 3.4% |
| Histology | ||
| No specimen collected | 43 | 36.1% |
| WHO Grade I | 38 | 31.9% |
| WHO Grade II | 20 | 16.8% |
| WHO Grade III | 18 | 15.1% |
| Karnofsky performance status | ||
| Median (range) | 80 | (30–100) |
| KPS ≥ 90% | 59 | 49.6% |
| KPS < 90% | 60 | 50.4% |
| Simpson resection grade (n = 79) | ||
| Not known | 7 | 5.9% |
| Grade I | 6 | 5.0% |
| Grade II | 12 | 10.1% |
| Grade III | 2 | 1.7% |
| Grade IV | 49 | 41.2% |
| Grade V | 3 | 2.5% |
| Treatment | ||
| Primary radiation | 37 | 31.1% |
| Adjuvant radiation | 19 | 16.0% |
| Relapse radiation | 63 | 52.9% |
| Radiation modalities | ||
| FSRT | 67 | 56.3% |
| IMRT | 48 | 40.3% |
| SRS | 3 | 2.5% |
| WBRT | 1 | 0.8% |
| Radiopeptide therapy | ||
| Yes | 9 | 7.6% |
| No | 110 | 92.4% |
FSRT = fractionated stereotactic radiotherapy; IMRT = intensity modulated radiotherapy; SD = standard deviation; SRS = stereotactic radiosurgery; WBRT = whole brain radiotherapy; WHO = World Health Organization.